Managing the Patient with Co-Morbid Depression and an Anxiety Disorder

Author： Schoevers Robert A. Van Henricus L. Koppelmans Vincent Kool Simone Dekker Jack J.

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.12, 2008-01, pp. : 1621-1634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Important to recognize and treat co-morbid depression in patients with restless legs syndrome

Drugs & Therapy Perspectives, Vol. 26, Iss. 12, 2010-12 ,pp. : 19-21

Adis International

Access to resources Recommend Favorite

Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

By Dell'Agnello Grazia

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 739-753

Adis International

Access to resources Recommend Favorite

Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence

By Pierucci-Lagha Amira Feinn Richard Modesto-Lowe Vania Swift Robert Nellissery Maggie Covault Jonathan Kranzler Henry

Psychopharmacology, Vol. 171, Iss. 3, 2004-01 ,pp. : 340-348

Springer Publishing Company

Access to resources Recommend Favorite

Use of Antidepressants in Older Patients with Co-Morbid Medical Conditions: Guidance from Studies of Depression in Somatic Illness

By Kennedy Gary J. Marcus Paula

Drugs & Aging, Vol. 22, Iss. 4, 2005-01 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

Targeting Brain Nicotinic Acetylcholine Receptors to Treat Major Depression and Co-Morbid Alcohol or Nicotine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 5, 2015-06 ,pp. : 647-653

Bentham Science Publishers

Access to resources Recommend Favorite